China
· Delayed Price · Currency is CNY Autobio Diagnostics Statistics
Total Valuation
Autobio Diagnostics has a market cap or net worth of CNY 23.08 billion. The enterprise value is 20.09 billion.
| Market Cap | 23.08B |
| Enterprise Value | 20.09B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 5, 2024 |
Share Statistics
Autobio Diagnostics has 576.89 million shares outstanding. The number of shares has decreased by -1.27% in one year.
| Shares Outstanding | 576.89M |
| Shares Change (YoY) | -1.27% |
| Shares Change (QoQ) | -3.66% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 15.57% |
| Float | 171.75M |
Valuation Ratios
The trailing PE ratio is 17.77 and the forward PE ratio is 16.39. Autobio Diagnostics's PEG ratio is 1.12.
| PE Ratio | 17.77 |
| Forward PE | 16.39 |
| PS Ratio | 5.05 |
| PB Ratio | 2.81 |
| P/FCF Ratio | 40.14 |
| PEG Ratio | 1.12 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.50, with an EV/FCF ratio of 34.95.
| EV / Earnings | 15.56 |
| EV / Sales | 4.42 |
| EV / EBITDA | 11.50 |
| EV / EBIT | 15.64 |
| EV / FCF | 34.95 |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 6.77.
| Current Ratio | 2.71 |
| Quick Ratio | 2.27 |
| Debt / Equity | 6.77 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 0.98 |
| Interest Coverage | 50.54 |
Financial Efficiency
Return on equity (ROE) is 15.84% and return on invested capital (ROIC) is 9.16%.
| Return on Equity (ROE) | 15.84% |
| Return on Assets (ROA) | 7.43% |
| Return on Capital (ROIC) | 9.16% |
| Revenue Per Employee | 820,151 |
| Profits Per Employee | 233,089 |
| Employee Count | 5,539 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.89% in the last 52 weeks. The beta is -0.06, so Autobio Diagnostics's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -13.89% |
| 50-Day Moving Average | 41.81 |
| 200-Day Moving Average | 50.89 |
| Relative Strength Index (RSI) | 44.26 |
| Average Volume (20 Days) | 3,221,128 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Autobio Diagnostics had revenue of CNY 4.54 billion and earned 1.29 billion in profits. Earnings per share was 2.25.
| Revenue | 4.54B |
| Gross Profit | 2.95B |
| Operating Income | 1.28B |
| Pretax Income | 1.44B |
| Net Income | 1.29B |
| EBITDA | 1.73B |
| EBIT | 1.28B |
| Earnings Per Share (EPS) | 2.25 |
Balance Sheet
The company has 3.63 billion in cash and 566.19 million in debt, giving a net cash position of 3.06 billion or 5.31 per share.
| Cash & Cash Equivalents | 3.63B |
| Total Debt | 566.19M |
| Net Cash | 3.06B |
| Net Cash Per Share | 5.31 |
| Equity (Book Value) | 8.36B |
| Book Value Per Share | 14.23 |
| Working Capital | 3.73B |
Cash Flow
In the last 12 months, operating cash flow was 1.43 billion and capital expenditures -854.06 million, giving a free cash flow of 574.85 million.
| Operating Cash Flow | 1.43B |
| Capital Expenditures | -854.06M |
| Free Cash Flow | 574.85M |
| FCF Per Share | 1.00 |
Margins
Gross margin is 65.00%, with operating and profit margins of 28.27% and 28.42%.
| Gross Margin | 65.00% |
| Operating Margin | 28.27% |
| Pretax Margin | 31.72% |
| Profit Margin | 28.42% |
| EBITDA Margin | 38.11% |
| EBIT Margin | 28.27% |
| FCF Margin | 12.65% |
Dividends & Yields
This stock pays an annual dividend of 1.05, which amounts to a dividend yield of 2.63%.
| Dividend Per Share | 1.05 |
| Dividend Yield | 2.63% |
| Dividend Growth (YoY) | 31.51% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.56% |
| Buyback Yield | 1.27% |
| Shareholder Yield | 3.90% |
| Earnings Yield | 5.63% |
| FCF Yield | 2.49% |
Stock Splits
The last stock split was on May 27, 2021. It was a forward split with a ratio of 1.3.
| Last Split Date | May 27, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3 |